Dynavax Technologies
DVAX
#5500
Rank
A$1.93 B
Marketcap
A$16.48
Share price
-0.18%
Change (1 day)
-17.74%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Market cap: A$1.93 Billion

As of December 2025 Dynavax Technologies has a market cap of A$1.93 Billion. This makes Dynavax Technologies the world's 5500th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025A$1.93 B-29.56%
2024A$2.74 B3.58%
2023A$2.65 B32.96%
2022A$1.99 B-14.31%
2021A$2.32 B265.06%
2020A$0.63 B-6.93%
2019A$0.68 B-16.08%
2018A$0.81 B-43.75%
2017A$1.45 B587.48%
2016A$0.21 B-83.44%
2015A$1.27 B135.27%
2014A$0.54 B-6.15%
2013A$0.57 B15.19%
2012A$0.50 B22.09%
2011A$0.41 B12.74%
2010A$0.36 B324.48%
2009A$85.8 M80.82%
2008A$47.45 M-79.58%
2007A$0.23 B-49.75%
2006A$0.46 B239.54%
2005A$0.13 B-44.34%
2004A$0.24 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Dynavax Technologies was reported to be:

A$1.93 Billion
by Nasdaq info icon info icon
A$1.93 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Agenus
AGEN
A$0.20 B-89.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$40.32 B 1,983.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$381.75 B 19,624.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$227.61 B 11,660.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$424.83 B 21,850.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
A$147.43 B 7,517.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
A$220.53 B 11,294.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$49.04 B 2,434.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
A$273.30 B 14,021.28%๐Ÿ‡บ๐Ÿ‡ธ USA